In a study published in Cell, Mount Sinai researchers found that fasting reduces inflammation and improves chronic inflammatory diseases without affecting the immune system’s response to acute infections.
Caloric excess, frequent in the Western world, has been linked to systemic low-grade chronic inflammation and is thought to contribute to numerous diseases including metabolic syndrome (MetS), non-alcoholic fatty liver diseases (NAFLD), type 2 diabetes mellitus (T2DM), atherosclerosis, cardiovascular disease (CVD), and other related co-morbidities. Accordingly, the recent diet westernization of developing countries has been associated with an increased prevalence of inflammatory or autoimmune disorders. In contrast, hypocaloric diets or fasting regimens are associated with improved outcomes of metabolic, autoimmune, and inflammatory diseases in humans, including NAFLD, T2DM, CVD, multiple sclerosis, rheumatoid arthritis, asthma and psoriasis, and have been shown to prolong lifespan.
Read the full research report here.
Scientific research on Intermittent Fasting
